- Report
- April 2025
- 85 Pages
Global
From €3500EUR$4,218USD£3,144GBP
- Report
- May 2026
- 150 Pages
Australia
From €4311EUR$4,850USD£3,741GBP
- Report
- May 2026
- 150 Pages
Brazil
From €4311EUR$4,850USD£3,741GBP
- Report
- May 2026
- 150 Pages
Canada
From €4311EUR$4,850USD£3,741GBP
- Report
- May 2026
- 150 Pages
Germany
From €4311EUR$4,850USD£3,741GBP
- Report
- May 2026
- 150 Pages
India
From €4311EUR$4,850USD£3,741GBP
- Report
- May 2026
- 150 Pages
Indonesia
From €4311EUR$4,850USD£3,741GBP
- Report
- May 2026
- 150 Pages
Italy
From €4311EUR$4,850USD£3,741GBP
- Report
- May 2026
- 150 Pages
Japan
From €4311EUR$4,850USD£3,741GBP
- Report
- May 2026
- 150 Pages
Malaysia
From €4311EUR$4,850USD£3,741GBP
- Report
- May 2026
- 150 Pages
Mexico
From €4311EUR$4,850USD£3,741GBP
- Report
- May 2026
- 150 Pages
Netherlands
From €4311EUR$4,850USD£3,741GBP
- Report
- May 2026
- 150 Pages
China
From €4311EUR$4,850USD£3,741GBP
- Report
- May 2026
- 150 Pages
Saudi Arabia
From €4311EUR$4,850USD£3,741GBP
- Report
- May 2026
- 150 Pages
South Africa
From €4311EUR$4,850USD£3,741GBP
- Report
- May 2026
- 150 Pages
South Korea
From €4311EUR$4,850USD£3,741GBP
- Report
- May 2026
- 150 Pages
Spain
From €4311EUR$4,850USD£3,741GBP
- Report
- May 2026
- 150 Pages
Thailand
From €4311EUR$4,850USD£3,741GBP
- Report
- May 2026
- 150 Pages
Turkey
From €4311EUR$4,850USD£3,741GBP
- Report
- May 2026
- 150 Pages
United Kingdom
From €4311EUR$4,850USD£3,741GBP

The Automated Breast Ultrasound System (ABUS) is a technology used in women's health to detect breast cancer. It is a non-invasive imaging technique that uses sound waves to create a three-dimensional image of the breast. This technology is used to supplement traditional mammography, which is the gold standard for breast cancer screening. ABUS is particularly useful for women with dense breast tissue, as it can detect smaller lesions that may be missed by mammography. It is also beneficial for women who are at high risk for breast cancer, as it can detect cancer at an earlier stage.
The ABUS market is growing rapidly, driven by increasing awareness of the importance of early detection of breast cancer and the need for improved screening methods. The market is expected to continue to grow in the coming years, driven by technological advancements and increasing demand for improved breast cancer screening.
Some of the major companies in the ABUS market include GE Healthcare, Siemens Healthineers, Hologic, FUJIFILM SonoSite, and Philips Healthcare. Show Less Read more